期刊： NEUROIMMUNOMODULATION, 2022; 29 (1)
Background: Traumatic brain injury (TBI) is posing serious health challenges for people across the globe due to high morbidity and mortality. However,......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Introduction: This study aimed to evaluate the regulatory mechanism of RAD18 in glioma development. Methods: RAD18 expression was compared in glioma t......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Background: Ischemic stroke is a major health issue that causes high incidents of morbidity and mortality worldwide. Irisin is an excise-induced prote......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (1)
Introduction: Physical exercise is an important component of managing Alzheimer's disease (AD). miRNAs can be modulated by exercise intervention. Obje......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Objective: At present, studies on lymphocytes are mostly conducted on CD19(+) B cells and CD27(+) B cells in neuromyelitis optica spectrum disorders (......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Background: Activated microglia can trigger pro-inflammatory cytokine releases and neuroinflammation, which may inhibit astrocytes to produce neurotro......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (1)
Introduction: Isoflurane inhalation leads to apoptotic neurodegeneration and further results in learning and cognitive dysfunction. Notoginsenoside R1......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (3)
Objective: The immunological features between neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and myelin oligodendrocyte glyc......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (1)
Introduction: Alzheimer's disease is the most popular neurodegenerative disorder with no effective drugs to stop the progression. Zuoguiwan (ZGW), a t......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Background: This study aimed to observe the changes of resting energy metabolism in patients with severe neurological diseases, and to explore the eff......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Background: Neuroinflammation subsequent to traumatic brain injury (TBI) is important for the recovery of patients and is associated with neurodegener......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Background: Elevation of AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC1 alpha) signali......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (3)
Introduction: This study aimed to explore the diagnostic value and effect of miR-381-3p on Alzheimer's disease (AD). Methods: RT-qPCR was used for the......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Seizures are a very common manifestation of autoimmune encephalitis (AE), ranging from 33% to 100% depending on the antigen, most often accompanied by......
期刊： NEUROIMMUNOMODULATION, 2022; 29 (4)
Stroke accounts for a large proportion of morbidity and mortality burden in China. Moreover, there is a high prevalence of the leading risk factors fo......
